Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
1 other identifier
interventional
27
1 country
1
Brief Summary
Cognitive impairment is common in Parkinson's disease. A recent study demonstrated 40% of people with PD suffer from mild cognitive impairment and \> 80% of patients develop dementia after a disease duration of 20 years. Cognitive impairment significantly impairs quality of life and has limited treatment options. While the pathophysiology of cognitive symptoms in PD is multifactorial, one contributing factor is dysfunction in subthalamic-cortical loops. The subthalamic nucleus (STN) receives input from distributed regions of the cortex, forming partially segregated parallel networks with sensorimotor regions, associative (cognitive) cortical regions, and limbic cortical regions. These subthalamic-cortical networks are thought to play a domain general role in inhibitory control, which is a fundamental mechanism underlying flexible behavior across motor, cognitive, and affective domains. Information processing in these subthalamic-cortical networks is expressed through oscillatory activity within distinct frequency bands. For example, communication between the STN and prefrontal regions involved in executive function is thought to occur through coherence in the theta (4-8 Hz) frequency band. As a result of these observations, stimulation of the STN at a theta frequency has been investigated as a method of modulating cognitive processes. Theta stimulation of the STN has been shown to enhance coherence in subthalamic-cortical networks, facilitating information processing and modulating behavior. For example, a recent study demonstrated that theta stimulation of the STN improved working memory performance in PD subjects, while no effect was seen for other frequency bands. The authors performed a post-hoc analysis and found that the effect may be mediated by connectivity between the stimulated STN region and the right dorsolateral prefrontal cortex (DLPFC). While these studies have demonstrated proof of principle, they are limited by small sample sizes and post-hoc analyses assessing the relationship between stimulation location and outcomes. Further research is needed to directly test the hypothesis that theta stimulation of the STN can improve executive control in PD patients by modulating associative STN circuitry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable parkinson-disease
Started Dec 2024
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2024
CompletedFirst Posted
Study publicly available on registry
July 24, 2024
CompletedStudy Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedNovember 25, 2024
November 1, 2024
9 months
July 10, 2024
November 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in working memory performance between conditions
Working memory performance will be assessed through a modified Sternberg task. Subjects will undergo the task with and without stimulation. Measures the main effect of stimulation condition, with hypothesis that theta stimulation of associative STN will improve performance compared to no stimulation. Outcome measured through percent of correctly recalled sequences.
Immediately after task performance
Secondary Outcomes (1)
Interaction effect between groups and stimulation condition
Immediately after task performance
Other Outcomes (1)
Correlation between working memory performance and STN connectivity
Immediately after task performance
Study Arms (4)
Stimulation off
SHAM COMPARATORThe deep brain stimulation device will be turned off.
Theta stimulation of associative STN region
EXPERIMENTALThe deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the associative STN region. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral stimulation is employed.
Theta stimulation of STN sensorimotor region
ACTIVE COMPARATORThe deep brain stimulation device will be set to a frequency of 6 Hz and will stimulate the sensorimotor region, acting as an anatomical control. If differential activation of the associative and sensorimotor STN networks is not feasible, dorsal stimulation is employed.
High frequency stimulation of associative STN region
ACTIVE COMPARATORThe deep brain stimulation device will be set to a frequency of 135 Hz and will stimulate the associative STN region, acting as a frequency control. If differential activation of the associative and sensorimotor STN networks is not feasible, ventral VTA is employed.
Interventions
The DBS device will be turned on while the patient undergoes the working memory task.
The DBS device will be turned off while the patient undergoes the working memory task.
Eligibility Criteria
You may qualify if:
- Those with STN DBS devices
- Those with pre- and post-operative imaging
- Those that are at least 3 months post-operative
You may not qualify if:
- Those unable to complete the cognitive task (due to language barriers or dementia)
- Those with significant DBS complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leslie and Gordan Diamond Health Care Centre
Vancouver, British Columbia, V5Z 1M9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD FRCSC
Study Record Dates
First Submitted
July 10, 2024
First Posted
July 24, 2024
Study Start
December 1, 2024
Primary Completion
September 1, 2025
Study Completion
October 1, 2025
Last Updated
November 25, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share